<code id='A4C6729B9A'></code><style id='A4C6729B9A'></style>
    • <acronym id='A4C6729B9A'></acronym>
      <center id='A4C6729B9A'><center id='A4C6729B9A'><tfoot id='A4C6729B9A'></tfoot></center><abbr id='A4C6729B9A'><dir id='A4C6729B9A'><tfoot id='A4C6729B9A'></tfoot><noframes id='A4C6729B9A'>

    • <optgroup id='A4C6729B9A'><strike id='A4C6729B9A'><sup id='A4C6729B9A'></sup></strike><code id='A4C6729B9A'></code></optgroup>
        1. <b id='A4C6729B9A'><label id='A4C6729B9A'><select id='A4C6729B9A'><dt id='A4C6729B9A'><span id='A4C6729B9A'></span></dt></select></label></b><u id='A4C6729B9A'></u>
          <i id='A4C6729B9A'><strike id='A4C6729B9A'><tt id='A4C6729B9A'><pre id='A4C6729B9A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:821
          A sign of AdventHealth on its building in Orlando, Florida — coverage from STAT
          Adobe

          A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with one party calling the other an “economic parasite.”

          The suit, between nonprofit hospital giant AdventHealth and MultiPlan, is now even attracting rare interest from the nation’s biggest hospital lobbyists.

          advertisement

          The new, highly detailed legal filings also come right as MultiPlan and more than a dozen of the largest tax-exempt, nonprofit hospital systems are wooing investors at the J.P. Morgan Healthcare Conference. AdventHealth did not attend this year’s conference, but did so last year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Do more moles mean more problems? Not so, says new study
          Do more moles mean more problems? Not so, says new study

          Thenumberofmolesisnotagoodindicatorofcancer'saggressiveness.APStockDermatologistsconstantlyhammerhom

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Merck to buy EyeBio, maker of eye drug, as it grows pipeline

          AdobeLONDON—MercksaidWednesdayitisbuyingophthalmology-focusedstartupEyeBioinadealworthupto$3billion,